Clinical Study on the Therapeutic Effects of Anti-Vascular Endothelial Growth Factor Therapy and Combined Steroid Therapy in Macular Edema Associated with Retinal Vein Occlusion in Relation to Cytokines

Clinical Study on the Therapeutic Effects of Anti-Vascular Endothelial Growth Factor Therapy and Combined Steroid Therapy in Macular Edema Associated with Retinal Vein Occlusion in Relation to Cytokines - Therapeutic Effects of Anti-VEGF Therapy Versus Steroid Combination in RVO

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049690

Enrollment

100

Registered

2023-02-21

Start date

2022-11-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with macular edema associated with retinal vein occlusion

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Patients with macular edema associated with retinal vein occlusion (2) Patients with visual acuity of 0.8 or less and central retinal thickness of 300um or more (3) Patients scheduled to receive anti-VGEF medication and expected to continue for at least 12 months (4) Patients who have not been treated with laser, surgery, or injections at other hospitals (5) Patients who have been informed of the purpose and content of this study and have given their free and voluntary consent (6) Patients who are able to visit the hospital and undergo examinations during the observation period

Exclusion criteria

Exclusion criteria: (1) Patients undergoing other ocular surgery or intravitreal injection of various drugs (2) Patients with the following diseases Patients with active uveitis Patients with iris neovascularization Patients with poorly controlled glaucoma Progressive diabetic retinopathy (3) Other patients deemed inappropriate for inclusion in the study by the investigator (4) Patients who refuse to cooperate in this study

Design outcomes

Primary

Measure	Time frame
Anti-VEGF treatment efficacy and cytokine levels	—

Countries

Japan

Contacts

Public ContactHidetaka Noma

Tokyo Medical University Hachioji Medical Center Department of Ophthalmology

nomahide1122@gmail.com+81426655611

Outcome results